144 related articles for article (PubMed ID: 37326123)
21. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
Valera A; Colomo L; Martínez A; de Jong D; Balagué O; Matheu G; Martínez M; Taddesse-Heath L; Jaffe ES; Bacchi CE; Campo E
Mod Pathol; 2013 Oct; 26(10):1329-37. PubMed ID: 23599149
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic Lymphoma Kinase positive large B cell lymphoma of ileocaecal mesentery: A case report.
Subramaniam A; Gnanasekaran D; Suruliraj S; Chinnusamy P
Indian J Pathol Microbiol; 2020; 63(4):615-617. PubMed ID: 33154317
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with emphasis on the cytological features of the pleural effusion.
Ishida M; Yoshida K; Kagotani A; Iwai M; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Yoshida T; Okuno T; Hodohara K; Okabe H
Int J Clin Exp Pathol; 2013; 6(11):2631-5. PubMed ID: 24228132
[TBL] [Abstract][Full Text] [Related]
25. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a potential diagnostic pitfall.
Yu H; Huang J; Sun J; Wang C; Lin M; Li H
Indian J Pathol Microbiol; 2015; 58(2):241-5. PubMed ID: 25885146
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience.
Salat H; Din NU; Moatter T; Kayani N; Ahmed A
Pathol Res Pract; 2017 Jun; 213(6):649-653. PubMed ID: 28551388
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity.
Li S
Int J Clin Exp Pathol; 2009 Mar; 2(6):508-18. PubMed ID: 19636398
[TBL] [Abstract][Full Text] [Related]
30. Tackling ALK-positive LBCL.
Frontzek F; Lenz G
Blood; 2022 Oct; 140(16):1751-1752. PubMed ID: 36264594
[No Abstract] [Full Text] [Related]
31. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
32. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement.
McManus DT; Catherwood MA; Carey PD; Cuthbert RJ; Alexander HD
Hum Pathol; 2004 Oct; 35(10):1285-8. PubMed ID: 15492998
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma: Diagnostic Perils and Pitfalls, an Underrecognized Entity.
Chowdhury Z
Cureus; 2021 Aug; 13(8):e16882. PubMed ID: 34513457
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Zanelli M; Valli R; Capodanno I; Ragazzi M; Ascani S
Int J Surg Pathol; 2015 Feb; 23(1):78-83. PubMed ID: 24868005
[TBL] [Abstract][Full Text] [Related]
35. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic lymphoma kinase-positive large B-cell lymphoma with a diagnostic pitfall of carcinoma: a case report.
Wei P; Jin M; Jiang L; Wang Y; Xie J; Hu X
Int J Clin Exp Pathol; 2017; 10(11):11219-11224. PubMed ID: 31966473
[TBL] [Abstract][Full Text] [Related]
37. ALK-positive diffuse large B-cell lymphoma: report of three cases.
Lee HW; Kim K; Kim W; Ko YH
Hematol Oncol; 2008 Jun; 26(2):108-13. PubMed ID: 18220322
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Gascoyne RD; Aoun P; Wu D; Chhanabhai M; Skinnider BF; Greiner TC; Morris SW; Connors JM; Vose JM; Viswanatha DS; Coldman A; Weisenburger DD
Blood; 1999 Jun; 93(11):3913-21. PubMed ID: 10339500
[TBL] [Abstract][Full Text] [Related]
39. Intravascular large B-cell lymphoma occurring 25 years after treatment of ALK-positive anaplastic large cell lymphoma.
McKelvie PA; Wools C; Roberts L; Cook M
Leuk Lymphoma; 2013 Dec; 54(12):2745-7. PubMed ID: 23488602
[No Abstract] [Full Text] [Related]
40. Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.
Li C; Takino H; Eimoto T; Ishida T; Inagaki A; Ueda R; Suzuki R; Yoshino T; Nakagawa A; Nakamura S; Inagaki H
Mod Pathol; 2007 Jun; 20(6):648-55. PubMed ID: 17464320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
